After outcry, drugmakers decide not t...

After outcry, drugmakers decide not to triple the price of a cancer pill

The makers of cancer drug Imbruvica declined to raise the price of the $148,000-a-year pill, despite developing a single-dose pill that could cost significantly more. The makers of cancer drug Imbruvica declined to raise the price of the $148,000-a-year pill, despite developing a single-dose pill that could cost significantly more.

Start the conversation, or Read more at The Orlando Sentinel.

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Business News Discussions

Title Updated Last By Comments
News Senate backs effort to restore a net neutrality... 4 hr BHM5267 13
News Congress doesn't want you to eat your dog or cat 9 hr HolyMolly 117
News Storage Will Be Energy's Next Big Thing 22 hr Solarman 1
News Senate votes for net neutrality return, but maj... May 17 He Named Me Black... 5
News Police: Rapper T.I. arrested outside his gated ... May 17 nope 2
News Amazon, Starbucks Blast Seattle Corporate Tax M... May 15 C Kersey 1
Big Beautiful Women Seeking Men At Free BBW Dat... (Aug '16) May 15 Brenda 11